✦ LIBER ✦

Feasibility of Radical Prostatectomy After Neoadjuvant Chemohormonal Therapy for Patients With High Risk or Locally Advanced Prostate Cancer: Results of a Phase I/II Study

✍ Scribed by KONETY, BADRINATH R.; EASTHAM, JAMES A.; REUTER, VICTOR E.; SCARDINO, PETER T.; DONAT, S. MACHELE; DALBAGNI, GUIDO; RUSSO, PAUL; HERR, HARRY W.; SCHWARTZ, LARRY; KANTOFF, PHILIP W.; SCHER, HOWARD; KELLY, W. KEVIN

Book ID: 123122085
Publisher: Lippincott Williams and Wilkins
Year: 2004
Tongue: English
Weight: 72 KB
Volume: 171
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000108122.36893.5a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter Phase II Study of Combined N

Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer

✍ Chi, Kim N.; Chin, Joseph L.; Winquist, Eric; Klotz, Laurence; Saad, Fred; Gleav 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 131 KB

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib

Re: Multicenter Phase II Study of Combin

Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer

✍ P. Beuzeboc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Long-term follow-up of a neoadjuvant che

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

✍ Tomaso Prayer-Galetti; Emilio Sacco; Francesco Pagano; Marina Gardiman; Antonio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Long-term results of a phase II study wi

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

✍ Thalgott, Mark; Horn, Thomas; Heck, Matthias M; Maurer, Tobias; Eiber, Matthias; 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 264 KB

Intense Androgen-Deprivation Therapy Wit

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

✍ Taplin, M.-E.; Montgomery, B.; Logothetis, C. J.; Bubley, G. J.; Richie, J. P.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 316 KB